跳至主要内容
临床试验/NCT02824016
NCT02824016已完成不适用

A Prospective Multicentric Evaluation of the Rate of Incidence of Hypothyroidism After Supraclavicular Irradiation for Breast Cancer

Institut Jean-Godinot6 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2013年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
500
试验地点
6
主要终点
Number of patients with treatment-related adverse effects on thyroid function as assessed by CTCAE v4.0

研究概览

简要总结

Prospective, multicentric, comparative, non randomised, in current care.

Primary objective:

  • To evaluate the incidence of hypothyroidism in breast cancer patients treated by radiotherapy including the supra-clavicular area over a period of 5 years (60 months).

Secondary objectives :

  • To calculate the dose of irradiation received by thyroid gland during the treatment.
  • To compare the rate of incidence of hypothyroidism in women who received a supra-clavicular irradiation (group 1)and in those who did not (group 2).
  • To estimate and compare the rate of incidence of chronic thyroid lesions in the 2 groups.
  • To look for predictive factors of hypothyroidism de novo in group 1 women particularly regarding the dose-volume parameters.
  • To propose recommendations for the thyroid follow-up after supra-clavicular irradiation.

详细描述

Prospective, multicentric, comparative, non randomised, in current care study

2 patient groups, non randomised, according to the necessity or not to perform a supra-clavicular irradiation:

  • Group 1 : patients receiving a supra-clavicular irradiation
  • Group 2 : patients not receiving a supra-clavicular irradiation.

Schedule

Projected inclusion duration of 18 months (duration to possibly adapt in order to obtain the number of required patients)

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Factorial
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women older than 18
  • Non metastatic breast cancer, histologically proved, whatever T and N stages and receptors status.
  • Breast cancer treated by surgery (either initial treatment then biotherapies and/or neoadjuvant chemotherapy, either secondarily after biotherapies and/or neoadjuvant chemotherapy, either without chemotherapy and/or biotherapies)
  • Breast cancer requiring an adjuvant radiotherapy
  • Treatment by radiotherapy made in participating centers
  • Information of patient and signature of the informed consent.

排除标准

  • Pre-existent dysthyroidism revealed before radiotherapy or at inclusion checkup (THS lower or superior to the standard of the laboratory, whatever the rate of free T4)
  • History of thyroid surgery
  • Bilateral breast cancer
  • History of cervical and/or supra-clavicular radiotherapy
  • Lack of social security insurance
  • Subjects deprived of free behavior or under administrative control

结局指标

主要结局

Number of patients with treatment-related adverse effects on thyroid function as assessed by CTCAE v4.0

时间窗: Outcome measures will be assessed every 6 months up to 5 years.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Tan Dat NGUYEN

Professor

Institut Jean-Godinot

研究点 (6)

Loading locations...

相似试验